Kardigan

Kardigan is a cardiovascular-focused biotechnology company founded by MyoKardia veterans. It aims to make cardiovascular disease preventable and curable. It uses a 'Cardiac Intelligence' platform that combines clinical trial data, real-world patient insights and analytics, and it builds its pipeline through internal R&D and in-licensing. Its programs target conditions such as genetic dilated cardiomyopathy, calcific aortic valve stenosis and acute severe hypertension.